Strategies for Treatment of Thyroid Cancer

被引:4
|
作者
Yadav, Deepika [1 ]
Sharma, Pramod Kumar [1 ]
Malviya, Rishabha [1 ]
Mishra, Prem Shankar [1 ]
机构
[1] Galgotias Univ, Sch Med & Allied Sci, Dept Pharm, Greater Noida, Uttar Pradesh, India
关键词
Thyroid cancer; radioactive iodine; molecular therapy; ablation treatment; thyroidectomy; novel target therapy; RET/PTC ONCOGENE ACTIVATION; PHASE-II TRIAL; RET PROTOONCOGENE; PAPILLARY CARCINOMAS; CURRENT DIAGNOSIS; KINASE INHIBITOR; HIGH-FREQUENCY; RAS; REARRANGEMENTS; TUMORS;
D O I
10.2174/1389450124666230222093308
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
More people are diagnosed with thyroid cancer than any other endocrine tumor. Differentiated thyroid cancer is often treated by removing the thyroid gland (thyroidectomy), iodizing radiation, or inhibiting thyroid stimulating hormone (TSH). Advanced thyroid carcinomas are notoriously resistant to chemotherapy, thus the pursuit of alternative treatments is vital. The best methods for treating individuals with advanced nonmedullary and medullary thyroid carcinomas are discussed in this post. Numerous tyrosine kinase inhibitors and antiangiogenic inhibitors, two types of novel target therapy, have shown promise in studies for individuals with thyroid cancer. Both the positive and unfavourable outcomes of clinical studies of these drugs were addressed. The findings presented here are encouraging, but more study is required to establish whether or not this method is effective in the treatment of thyroid cancer.
引用
收藏
页码:406 / 415
页数:10
相关论文
共 50 条
  • [31] PROPHYLACTIC THYROID TREATMENT IN CANCER
    HANDLER, JJ
    WYATT, DG
    BRITISH MEDICAL JOURNAL, 1955, 1 (FEB12): : 417 - 417
  • [32] THYROID CANCER AND ITS TREATMENT
    WELCH, JW
    HELLWIG, CA
    CHESKY, VE
    MCCUSKER, EN
    SURGERY GYNECOLOGY & OBSTETRICS, 1959, 109 (01): : 27 - 37
  • [33] TREATMENT OF THYROID-CANCER
    BENUA, RS
    JOURNAL OF NUCLEAR MEDICINE, 1985, 26 (01) : 8 - 8
  • [34] BLEOMYCIN TREATMENT FOR CANCER OF THYROID
    HARADA, T
    NISHIKAWA, Y
    SUZUKI, T
    ITO, K
    BABA, S
    AMERICAN JOURNAL OF SURGERY, 1971, 122 (01): : 53 - +
  • [35] DIAGNOSIS AND TREATMENT OF THYROID CANCER
    TAYLOR, S
    STEINER, H
    EGDAL, HR
    ROHER, HD
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1976, 343 (01): : 1 - 10
  • [36] HORMONAL TREATMENT OF THYROID CANCER
    THOMAS, CG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1957, 17 (02): : 232 - 237
  • [37] SURGICAL TREATMENT OF CANCER OF THYROID
    DAMIAN, A
    ANGELESCU, E
    STOENESCU, D
    OPROIU, A
    ACTA CHIRURGICA BELGICA, 1975, 74 (05) : 474 - 482
  • [38] Sorafenib in the treatment of thyroid cancer
    Ferrari, Silvia Martina
    Politti, Ugo
    Spisni, Roberto
    Materazzi, Gabriele
    Baldini, Enke
    Ulisse, Salvatore
    Miccoli, Paolo
    Antonelli, Alessandro
    Fallahi, Poupak
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (08) : 863 - 874
  • [39] Treatment of refractory thyroid cancer
    Berdelou, Amandine
    Lamartina, Livia
    Klain, Michele
    Leboulleux, Sophie
    Schlumberger, Martin
    ENDOCRINE-RELATED CANCER, 2018, 25 (04) : R209 - R223
  • [40] Vandetanib for the Treatment of Thyroid Cancer
    Langmuir, P. B.
    Yver, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (01) : 71 - 80